OTCMKTS:CLABF Core One Labs (CLABF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Core One Labs Stock (OTCMKTS:CLABF) Get Core One Labs alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.00▼$0.0352-Week Range N/AVolumeN/AAverage Volume11,414 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Core One Labs Inc. (OTCMKTS: CLABF) is a clinical-stage biotechnology company specializing in the development and commercialization of proprietary cannabinoid drug-delivery platforms. The company’s core focus lies in creating advanced formulations to improve the bioavailability, stability and controlled release of cannabinoids, including cannabidiol (CBD) and other minor cannabinoids, for therapeutic applications. By leveraging enzyme-catalyzed, isotopically labeled synthesis technology, Core One Labs aims to address key challenges in consistency and dosing that have historically limited the broader pharmaceutical adoption of cannabinoid-based therapies. At the heart of Core One Labs’ business model is its exclusive licensing agreement with the University of Mississippi, which grants the company access to patented stable-isotope labeling techniques for cannabinoid molecules. This platform enables Core One Labs to generate analytical reference standards and develop novel drug candidates designed to treat a range of central nervous system disorders, including pain management, epilepsy and inflammatory conditions. The company operates a state-of-the-art development facility in Florida, where it advances its research-stage pipeline and provides contract manufacturing and custom synthesis services to strategic partners in the pharmaceutical, health-and-wellness and consumer goods sectors. Core One Labs’ leadership team brings together experts in pharmaceutical chemistry, regulatory affairs and clinical development to guide the company through its transition from early-stage research to regulatory submission. While the company’s initial focus is on advancing IND-enabling studies for its lead cannabinoid formulations, it also explores strategic collaborations to broaden its product portfolio. Core One Labs serves customers and research collaborators primarily in the United States, with the potential to extend its technology to international markets as regulatory frameworks for cannabinoid-based medicines evolve.AI Generated. May Contain Errors. Read More Receive CLABF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLABF Stock News HeadlinesCore One Labs Inc. (CLABF) - Yahoo FinanceJuly 13, 2025 | finance.yahoo.comQuest PharmaTech Inc. (QPT.V) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comTrump cannot stop this trainThere are five truths reshaping America’s financial future — and ignoring them could be costly. From an overextended government and vanishing savings to AI-driven job displacement and a widening wealth divide, the warning signs are clear. But according to Porter Stansberry, these same forces are also driving one of the largest wealth transfers in history. His new exposé, The Final Displacement, reveals the economic blueprint behind these shifts — and the final step he believes every American must take to protect and grow their wealth before it’s too late.October 24 at 2:00 AM | Porter & Company (Ad)NurExone Biologic Inc. (J90.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comCockroach Labs shakes up its licensing to force bigger companies to payAugust 15, 2024 | yahoo.comKlipsch Flexus Core 100 Review: Great Sound from Single BarMay 27, 2024 | msn.comCLB Core Laboratories Inc.April 24, 2024 | seekingalpha.comCore One Labs Inc. (CLABF)February 23, 2024 | finance.yahoo.comSee More Headlines CLABF Stock Analysis - Frequently Asked Questions How do I buy shares of Core One Labs? Shares of CLABF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:CLABF CIK1640152 Webcore1labs.com Phone(866) 452-6731FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:CLABF) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredTrump cannot stop this trainGallup reports that two-thirds of Americans now view socialism favorably — a shocking shift that one analyst s...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core One Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core One Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.